Get notified when BIAF files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsbioAffinity Technologies receives Mexican patent allowance for lung cancer detection method
Filed May 27, 2026 · Period ending May 27, 2026 · ~1 min read
Key Changes
-
medium
The Mexican Institute of Industrial Property has allowed a patent application covering methods to predict lung cancer likelihood using flow cytometry technology, strengthening the company's international IP portfolio.
Item 7.01 Press Release view on EDGAR → -
medium
This patent allowance expands bioAffinity's intellectual property protection beyond the U.S., potentially creating barriers to competition in the Mexican market for its diagnostic technology.
Item 7.01 view on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SNOA 10-K) is open in full — no account needed.
Partner
Trade BIAF commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · May 28, 2026 5:35 AM